The influence of cardiovascular morbidity on the prognosis in prostate cancer. Experience from a 12-year nationwide Danish population-based cohort study

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Jespersen, Christina G ^a   Nørgaard, Mette ^a   Bjerklund Johansen, Truls E ^a   Søgaard, Mette ^a   Borre, Michael ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; HEART DEATH; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OVERALL SURVIVAL; PROGNOSIS; PROSTATE CANCER; STROKE; COMORBIDITY; HEART MUSCLE ISCHEMIA; INCIDENCE; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PROSTATE TUMOR; REGRESSION ANALYSIS; RISK FACTOR; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMORBIDITY; DENMARK; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROGNOSIS; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; RISK FACTORS; STROKE; SURVIVAL ANALYSIS;

EID: 83455162909     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-519     Document Type: Article

References (29)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer Statistics, 2010. CA Cancer J Clin 2010,
2. National Board of Health Cancer profile -prostate cancer (2000-2007). http://www.sst.dk/Publ/Publ2009/EPT/Kraeftprofiler/Tabelvaerk_prostatakraeft2000-2007.pdf, National Board of Health.
3. Lund L, Borre M, Jacobsen J, Sorensen HT, Norgaard M. Impact of comorbidity on survival of Danish prostate cancer patients, 1995-2006: a population-based cohort study. Urology 2008, 72:1258-1262. 10.1016/j.urology.2007.12.018, 18342917.
4. Houterman S, Janssen-Heijnen ML, Hendrikx AJ, van der Berg HA, Coebergh JW. Impact of comorbidity on treatment and prognosis of prostate cancer patients: a population-based study. Crit Rev Oncol Hematol 2006, 58:60-67. 10.1016/j.critrevonc.2005.08.003, 16213153.
5. Post PN, Hansen BE, Kil PJ, Janssen-Heijnen ML, Coebergh JW. The independent prognostic value of comorbidity among men aged < 75 years with localized prostate cancer: a population-based study. BJU Int 2001, 87:821-826.
6. Lu-Yao G, Stukel TA, Yao SL. Changing patterns in competing causes of death in men with prostate cancer: a population based study. J Urol 2004, 171:2285-2290. 10.1097/01.ju.0000127740.96006.1a, 15126804.
7. Marr PL, Elkin EP, Arredondo SA, Broering JM, DuChane J, Carroll PR. Comorbidity and primary treatment for localized prostate cancer: data from CaPSURE. J Urol 2006, 175:1326-1331. 10.1016/S0022-5347(05)00647-6, 16515991.
8. Schymura MJ, Kahn AR, German RR, Hsieh MC, Cress RD, Finch JL, Fulton JP, Shen T, Stuckart E. Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1). BMC Cancer 2010, 10:152. 10.1186/1471-2407-10-152, 2876077, 20403178.
9. Harlan LC, Potosky A, Gilliland FD, Hoffman R, Albertsen PC, Hamilton AS, Eley JW, Stanford JL, Stephenson RA. Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study. J Natl Cancer Inst 2001, 93:1864-1871. 10.1093/jnci/93.24.1864, 11752011.
10. The European Heart Network European cardiovascular diseases statistics (2008). http://www.ehnheart.org/cdv-statistics.html, The European Heart Network.
11. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation 2011, 123:e18-e209. 10.1161/CIR.0b013e3182009701, 21160056.
12. Department of Clinical Epidemiolgy Acute myocardial infarction -occurrence and prognosis (2008).http://kea.au.dk/files/43.pdf, Department of Clinical Epidemiolgy.
13. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999, 353:1547-1557. 10.1016/S0140-6736(99)04021-0, 10334252.
14. Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 2004, 109:1101-1107. 10.1161/01.CIR.0000118498.35499.B2, 14993137.
15. Frank L. Epidemiology. When an entire country is a cohort. Science 2000, 287:2398. 10.1126/science.287.5462.2398, 10766613.
16. Storm HH, Michelsen EV, Clemmensen IH, Phil J. The Danish Cancer Registry--history, content, quality and use. Dan Med Bull 1997, 44:535-539.
17. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999, 46:263-268.
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373. 10.1016/0021-9681(87)90171-8, 3558716.
19. Platz EA, Leitzmann MF, Visvanathan K, Rimm EB, Stampfer MJ, Willett WC, Giovannucci E. Statin drugs and risk of advanced prostate cancer. J Natl Cancer Inst 2006, 98:1819-1825. 10.1093/jnci/djj499, 17179483.
20. Jacobs EJ, Rodriguez C, Bain EB, Wang Y, Thun MJ, Calle EE. Cholesterol-lowering drugs and advanced prostate cancer incidence in a large U.S. cohort. Cancer Epidemiol Biomarkers Prev 2007, 16:2213-2217. 10.1158/1055-9965.EPI-07-0448, 17971518.
21. Murtola TJ, Tammela TL, Lahtela J, Auvinen A. Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2007, 16:2226-2232. 10.1158/1055-9965.EPI-07-0599, 18006910.
22. Lund L, Jacobsen J, Noergaard M, McLaughlin JK, Blot WJ, Borre M, Sørensen HT. The prognostic impact of comorbidities on renal cancer, 1995 to 2006: a Danish population based study. J Urol 2009, 182:35-40. 10.1016/j.juro.2009.02.136, 19450859.
23. Cronin-Fenton DP, Nørgaard M, Jacobsen J, Garne JP, Ewertz M, Lash TL, Sørensen HT. Comorbidity and survival of Danish breast cancer patients from 1995 to 2005. Br J Cancer 2007, 96:1462-1468. 2360185, 17406360.
24. Tetsche MS, Nørgaard M, Jacobsen J, Wogelius P, Sørensen HT. Comorbidity and ovarian cancer survival in Denmark, 1995-2005: a population-based cohort study. Int J Gynecol Cancer 2008, 8:421-427.
25. Iversen LH, Nørgaard M, Jacobsen J, Laurberg S, Sørensen HT. The impact of comorbidity on survival of Danish colorectal cancer patients from 1995 to 2006--a population-based cohort study. Dis Colon Rectum 2009, 52:71-78. 10.1007/DCR.0b013e3181974384, 19273959.
26. Johnsen SP, Overvad K, Sorensen HT, Tjoenneland A, Husted SE. Predictive value of stroke and transient ischemic attack discharge diagnoses in The Danish National Registry of Patients. J Clin Epidemiol 2002, 55:602-607. 10.1016/S0895-4356(02)00391-8, 12063102.
27. Joensen AM, Jensen MK, Overvad K, Dethlefsen C, Schmidt E, Rasmussen L, Tjonneland A, Johnsen S. Predictive values of acute coronary syndrome discharge diagnoses differed in the Danish National Patient Registry. J Clin Epidemiol 2009, 62:188-194. 10.1016/j.jclinepi.2008.03.005, 18722087.
28. Madsen M, Davidsen M, Rasmussen S, Abildstrom S, Osler M. The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol 2003, 56:124-130. 10.1016/S0895-4356(02)00591-7, 12654406.
29. Glass TR, Tangen CM, Crawford ED, Thompson I. Metastatic carcinoma of the prostate: identifying prognostic groups using recursive partitioning. J Urol 2003, 169:164-169. 10.1016/S0022-5347(05)64059-1, 12478127.